Bio-Rad Laboratories Inc
Company Profile
Business description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Contact
1000 Alfred Nobel Drive
HerculesCA94547
USAT: +1 510 724-7000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
7,700
Stocks News & Analysis
stocks
Going into earnings, is Netflix stock a buy, a sell, or fairly valued?
stocks
Bapcor is paying for the sins of its past
stocks
Overvalued ASX share as market underestimates downside risks
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,390.10 | 16.40 | 0.17% |
CAC 40 | 8,243.94 | 37.87 | 0.46% |
DAX 40 | 24,277.59 | 18.79 | 0.08% |
Dow JONES (US) | 46,737.93 | 31.35 | 0.07% |
FTSE 100 | 9,429.81 | 26.24 | 0.28% |
HKSE | 26,027.55 | 168.72 | 0.65% |
NASDAQ | 22,961.94 | 28.61 | -0.12% |
Nikkei 225 | 49,316.06 | 130.56 | 0.27% |
NZX 50 Index | 13,377.85 | 32.89 | 0.25% |
S&P 500 | 6,734.85 | 0.28 | -0.00% |
S&P/ASX 200 | 9,094.70 | 18.80 | 0.21% |
SSE Composite Index | 3,916.33 | 52.44 | 1.36% |